Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
OrigiMed Completes Series B Round Focusing on Creating a Comprehensive Precision Medicine Platform for Oncology
2019-01-04 09:30
MabSpace Biosciences Merged with HJB to Form Transcenta Holding, a Fully Integrated Leading Global Biotherapeutics Company
2019-01-02 12:37
MEDI FUTURES Raises US$5M Funding Led by Samho Green Investment
2018-12-28 21:00
Bridge Biotherapeutics Announces a Successful Activation of U.S. Clinical Trial Sites for BBT-401 Phase 2 Study
2018-12-28 07:00
Bridge Biotherapeutics Signs US$40M License Agreement with Daewoong Pharmaceutical for Co-development of UC Drug Candidate
2018-12-19 08:00
NeuClone Announces its Sixth Biosimilar Candidate Perjeta(R) (Pertuzumab) for use in Combination Therapy with Herceptin(R) (Trastuzumab)
2018-12-17 21:30
lululab Named as CES 2019 Innovation Awards Honoree
2018-12-17 21:00
I-Mab and CSPC Pharma Announce Strategic Partnership for Long-acting GLP-1 Fc Program
2018-12-17 19:10
China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman
2018-12-14 21:00
Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints
2018-12-13 08:00
Cathay Industrial Biotech Invests an Additional USD 500 Million to Expand its Production Capacity for New Bio-based Materials
2018-12-11 20:45
GenEdit Closes $8.5 million Series Seed Financing
2018-12-11 13:17
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services
2018-12-10 16:00
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market"
2018-12-06 18:12
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
2018-11-29 15:40
An Animal Test Demonstrated that Lactic Acid Bacteria Isolated from Kimchi Enhance Immunity
2018-11-28 22:00
WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies
2018-11-28 19:44
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan
2018-11-28 08:00
Lactic Acid Bacteria in Kimchi Reduce Cholesterol in Blood
2018-11-26 22:00
Foresee Pharmaceuticals Announces Completion of Last Patient Visit in Registration Phase 3 Study of LMIS 25 mg (fp-001) for the Treatment of Advanced Prostate Cancer
2018-11-26 21:30
1
131
132
133
134
135
220